Methadone

Methadone is a synthetic painkiller that became a treatment for opioid withdrawal and a central, though often contested, form of medication-assisted treatment. Its history in Dopesick exposes a recurring divide: while medical institutions and companies expanded opioid use for pain, treatment medicines for addiction remained subject to suspicion, restrictive rules, and uneven access. The book’s later account of a rural Tennessee clinic makes that divide concrete, showing how the cost and daily administration of methadone could make it a practical option even as its presence provoked community concern.

Origins and Medical Use

Methadone was developed as a painkiller for battlefield injuries. Shortly after World War II, American researchers encountered it in German laboratories and learned that it could quell opioid withdrawal. That discovery made the drug useful not only as a pain medicine but also as a basis for maintenance treatment for people addicted to morphine or heroin.

The drug’s therapeutic promise did not settle the question of whether one drug should be used to treat dependence on another. The Federal Bureau of Narcotics, the predecessor of the Drug Enforcement Administration, opposed methadone treatment. It characterized the medicine as unsafe after studies found that morphine-dependent patients liked its effects, and in the 1960s it harassed the small number of physicians using methadone to treat morphine and heroin addiction. The dispute revealed how difficult it was to separate a medicine’s capacity to relieve withdrawal from anxieties that it might also be pleasurable or misused.

Regulation and the Treatment Divide

During the following decade, researchers sought compounds that could block opioid euphoria and dangerous respiratory depression, including effects associated with methadone. This work contributed to the development of later maintenance treatments, including buprenorphine and naltrexone. Methadone, however, remained on the margins of medical respectability for decades.

The Nixon administration turned to methadone as a response to crime and concern about returning Vietnam War veterans. The book reports that 20 percent of veterans were coming home addicted to opium or morphine, at a rate of 1,400 soldiers per month. Officials did not trust doctors to dispense the drug and control its diversion in ordinary offices, so highly regulated, stand-alone methadone clinics became the norm.

That restrictive approach stands in sharp contrast to the era of expanded opioid prescribing. Through 2016, doctors could prescribe opioid painkillers liberally, while treatment with methadone and buprenorphine remained heavily regulated. The book sets methadone’s controlled clinic system against the widespread institutional promotion of opioid pain treatment, including the adoption of pain as the fifth vital sign and the expansion of assessment and treatment standards. The contrast is not simply between two medicines: it is between systems that made opioid pain relief broadly available and systems that kept addiction treatment comparatively difficult to obtain.

Access, Cost, and Rural Distance

The difficulties of access appear in the account of Tess Henry’s treatment during pregnancy. The Life Center of Galax was one of the few Virginia facilities that accepted patients receiving medication-assisted treatment, including methadone or buprenorphine. Tess received buprenorphine rather than methadone, but the facility’s limited acceptance of patients on either medicine shows how narrow the available treatment path could be. The account also notes that some newborns exposed to medication in utero required hospital care and methadone treatment to support withdrawal, extending the drug’s role into the care of infants experiencing neonatal abstinence syndrome.

In Gray, Tennessee, the proposed Overmountain Recovery clinic offered a different response to the distance separating rural patients from treatment. The clinic was designed to provide counseling and other supports alongside medication, and was expected to offer some Suboxone while operating predominantly as a methadone clinic. Methadone was less expensive and harder to divert because patients would drink the liquid dose daily in front of a nurse. The nearest methadone facility in the region was about sixty miles away, over a mountain, making the new clinic a practical answer to a substantial geographic barrier.

Community Conflict and Significance

Overmountain Recovery’s plan met resistance from Citizens to Maintain Gray, whose members worried that patients taking methadone would be too impaired to drive safely. Some residents opposed having the clinic nearby even while privately acknowledging that their own sons were dealing with addiction. The working group responded by listening to opponents and bringing in outside police chiefs and methadone providers to present examples and studies from other communities. The clinic opened in September 2017 after a difficult approval process that won near-unanimous support from the city zoning board and the state.

Methadone’s place in the book is therefore defined by more than its clinical use. It is a medicine that can ease opioid withdrawal and support maintenance, yet its history is marked by institutional distrust, tightly supervised delivery, and local fears about diversion and safety. Overmountain Recovery illustrates the possibility of embedding medication in a broader program of counseling, job-training support, and community-based care. Its long journey to opening also shows that treatment access depends not only on a medicine’s availability, but on whether institutions and communities will make room for the people who need it.